Propranolol release

Hydroserpine 2 Tablets—hydrochbrothiazide, reserpine Hyzaar—hydrochlorothiazide, losartan potassium Inderide—hydrochlorotliiazide, propranolol HC1 Inderide LA—hydrochlorotliiazide, propranolol HC1 Lexxel Extended-Release—enalapril maleate, felodipine Lopressor—hydrochlorothiazide, metoprolol Lotensin HCT—hydrochlorothiazide, benazepril Lotrel—amlodopine, benazepril... 

Adverse Effects The most common adverse effects are gastrointestinal upset, tremor, and polyuria,30 which are dose-related. Nausea, dyspepsia, and diarrhea can be minimized by coadministration with food, use of sustained-release formulations, and giving smaller doses more frequently to reduce the amount of drug in the gastrointestinal tract at a given time. Tremor is present in up to 50% of patients. In addition to the approaches above, low-dose P-blocker therapy such as propranolol 20 to 60 mg/day often reduces the tremor. 

Ubrich, N., Bouillot, Ph., Pellerin, Ch., Hoffman, M. and Maincent Ph. (2004) Preparation of propranolol hydrochloride nanopartides a comparative study. Journal of Controlled Release, 97 291-300. 

Fig. 20.13. Potential H-bonding energy, released upon interaction with the transmembrane domains of P-gp (in arbitrary energy units, EU) for progesterone (1), propranolol (2), amitriptyline (3), diltiazem (4), amiodarone (5), colchicine (7), gramicidin S (8), daunorubicin (9), vinblastine (10), cyclosporin A, in comparison with verapamil...

The answer is d. (Hardman, p 1401.) In patients who are suspected of having hyperthyroidism, propranolol can be administered to provide temporary relief of the peripheral manifestations of the disease while the patient is further evaluated. Propranolol suppresses adrenergic symptoms such as tremors and tachycardia it has no effect on the release of thyroid hormones from the gland. 

The release kinetics from the tablets of the drug-polymer complexes were carried out in buffered release media containing 0.01 M phosphate and NaCl ranging from 0.2 M to 0.02 M at 37°C by the USP basket method at 100 rpm. Drug release was monitored on a HP 8452A diode-array spectrophotometer at 250, 306, 306, 270, 278, 278, and 274 nm for sodium diclofenac and sulfathiazole, labetalol HCl, propranolol HCl, verapamil HCl, and diltiazem HCl, respectively. 

For highly potent APIs, profound effects can occur at low ng levels, the adverse effect of ethynylestradiol on fish populations is one example [107]. Another example is the development of resistant bacterial strains induced by the release of antibiotics into the environment [112, 113]. Dome et al. [114] concluded that fluoxetine, ibuprofen, diclofenac, propranolol and metoprolol exhibit relatively high acute toxicity to aquatic species. In addition, due to the inherent properties of these chemicals, pharmacodynamic effects were observed in the heart rate of Daphnia magna for the (3-blockers propranolol and metoprolol. 

Propranolol lowers blood pressure in the majority of patients with essential hypertension. These effects can be caused by a number of possible mechanisms, including lowering cardiac output, inhibiting the release of renin, lowering sympathetic release from the central nervous system, inhibiting the release of norepinephrine from sympathetic postganglionic nerves, and others. 

Deficiency of adrenal medullary catecholamines appears to give no ill effects, and replacement therapy is therefore not used, but adrenal medullary tumours, phaeochromocytomas, secrete excess catecholamines often causing hypertension with dramatic episodes of headache, palpitations, pallor, sweating and anxiety. This condition is normally treated surgically, but preoperative preparation is mandatory to avoid catastrophic effects of surges of catecholamine release. A combination of alpha- and beta-adrenergic receptor blockade is normally used, with drugs such as phenoxybenzamine or doxazosin as alpha-blockers, and propranolol as a non-selective beta-blocker. 

There is extensive evidence consistent with a role for CRH in mediating stress effects on memory consohdation. Activation of CRH receptors in the BLA by CRH released from the CEA facilitates stress effects on memory consohdation. Memory enhancement produced by CRH infusions in the hippocampus are blocked by propranolol, suggesting CRH, through a presynaptic mechanism, stimulates NE release in the hippocampus (Roozendaal et al. 2002). 

Topical release and permeation studies of propranolol hydrochloride from hydrophilic polymeric matrices... 

In the light of these observations and the newer trends in product formulation, it was decided to study the in vitro release and permeation of propranolol hydrochloride from various hydrophilic polymeric matrices using the cellulose membrane and the hairless mouse skin as the diffusion barriers and to evaluate the effects of some of the additive ingredients known to enhance drug release from dermatological bases. 

In vitro release data of propranolol hydrochloride from the four formulations evaluated ovr a 24 h period are shown in Table 2. The decreasing rank order of drug release from these samples was observed to be as follows Methocel matrix> Avicel CL-611 matrix>PVA-gelatin matrix>emulsion base. The Methocel matrix, formulation A, exhibited the maximum release of the drug, whereas the drug released was at a minimum from the PVA-gelatin matrix, formulation... 

C. This could be attributed to the possible cross-linkages formed between the two polymers which thus restricted the movement of the drug molecules within the gel. The release of propranolol hydrochloride from the emulsion base, formulation D, was relatively low compared with all the hydrophilic polymeric gel formulations. This suggests that, for a water-soluble drug such as propranolol hydrochloride, polymeric-gel-based formulations are clearly the better vehicles for developing such dosage forms. 

Table 3—In vitro release-permeation of propranolol hydrochloride from Methocel matrix formulation in the presence of the additive ingredients using cellulose membrane...

Table 5 Drug release from Methocel matrix formulation containing varied concentrations of propranolol hydrochloride...

Fig. 2—Effect of drug loading on the release profile of propranolol hydrochloride from Methocel matrix (V), 3.0% 0,2.0% , 1.0% o,0.5%.

Most of the drugs in this class are well absorbed after oral administration peak concentrations occur 1-3 hours after ingestion. Sustained-release preparations of propranolol and metoprolol are available. 

See Table 11-2. Resting bradycardia and a reduction in the heart rate during exercise are indicators of propranolol s 3-blocking effect, and changes in these parameters may be used as guides for regulating dosage. Propranolol can be administered twice daily, and slow-release preparations are available. 

The nonselective agents, phentolamine and phenoxybenzamine, are useful in diagnosis and treatment of pheochromocytoma and in other clinical situations associated with exaggerated release of catecholamines (eg, phentolamine may be combined with propranolol to treat the clonidinewithdrawal syndrome, described previously). Their pharmacology is described in Chapter 10. 

---